EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.24.46 | Neoplasms |
14598310 |
ADAMs family members as amyloid precursor protein alpha-secretases. |
causal interaction
therapeutic application
unassigned |
1
4
0 |
| 3.4.24.46 | Neoplasms |
17028596 |
MicroRNAs and the hallmarks of cancer. |
causal interaction
unassigned |
3
0 |
| 3.4.24.46 | Neoplasms |
19718658 |
Alternative splicing of ADAM15 regulates its interactions with cellular SH3 proteins. |
causal interaction
unassigned |
1
0 |
| 3.4.24.46 | Neoplasms |
20064929 |
P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and ErbB3 in human salivary gland cells. |
causal interaction
unassigned |
1
0 |
| 3.4.24.46 | Neoplasms |
29963134 |
Tumor angiogenesis and anti-angiogenic gene therapy for cancer. |
ongoing research
therapeutic application
unassigned |
2
3
0 |
| 3.4.24.46 | Oligodendroglioma |
22406378 |
Microvesicles shed by oligodendroglioma cells and rheumatoid synovial fibroblasts contain aggrecanase activity. |
ongoing research
therapeutic application
unassigned |
3
1
0 |
| 3.4.24.46 | Osteoarthritis |
10419777 |
Regulation of tumor necrosis factor-alpha and tumor necrosis factor converting enzyme in human osteoarthritis. |
unassigned |
0 |
| 3.4.24.46 | Osteoarthritis |
33381768 |
Interleukin 13 (IL-13)-regulated expression of the chondroprotective metalloproteinase ADAM15 is reduced in aging cartilage. |
diagnostic usage
ongoing research
therapeutic application
unassigned |
1
4
4
0 |
| 3.4.24.46 | Purpura, Thrombotic Thrombocytopenic |
23743117 |
Complement activation in diseases presenting with thrombotic microangiopathy. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
